Chronic Myelogenous Leukemia Treatment Companies

This report lists the top Chronic Myelogenous Leukemia Treatment companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Chronic Myelogenous Leukemia Treatment industry.

Chronic Myelogenous Leukemia Treatment Top Companies

  1. Bristol-Myers Squibb

  2. Pfizer

  3. Teva Pharmaceutical Industries

  4. Takeda Pharmaceuticals

  5. Novartis

*Disclaimer: Top companies sorted in no particular order

Chronic Myelogenous Leukemia Treatment Market Major Players

Chronic Myelogenous Leukemia Treatment Market Concentration

Chronic Myelogenous Leukemia Treatment Market Concentration

Chronic Myelogenous Leukemia Treatment Company List

  • Bristol-Myers Squibb Co.

  • Novartis AG

  • Pfizer Inc.

  • Takeda Pharmaceutical Company Limited

  • Teva Pharmaceutical Industries Ltd.

  • Viatris Inc. (Mylan)

  • Merck & Co., Inc.

  • F. Hoffmann-La Roche Ltd.

  • Boehringer Ingelheim International GmbH

  • Sanofi

  • Cipla Inc. (Cipla USA Inc.)

  • Amneal Pharmaceuticals LLC

  • Accord Healthcare, Inc

  • Fresenius Kabi AG


Specific to Chronic Myelogenous Leukemia Treatment Market
Need More Details on Market Players and Competitors?
Download PDF

Chronic Myelogenous Leukemia Treatment Market Report Snapshots

Chronic Myelogenous Leukemia Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)